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        Excess production of Reactive Oxygen Species (ROS), which can be caused by 
radiation, cigarette smoke, and pollutants, can cause many damaging cellular effects, 
such as DNA damage and unregulated cell apoptosis. If left unmitigated, chronic 
overproduction of ROS has been linked to the formation of cancer, diabetes, 
atherosclerosis, rheumatoid arthritis, chronic inflammation, Parkinson’s disease, 
Alzheimer’s disease, multiple sclerosis, and amyotrophic lateral sclerosis. ROS is 
typically eliminated with antioxidants, which scavenge and inhibit the formation of ROS 
by becoming oxidized by the ROS and by binding to its precursors.  
         Curcumin is an effective lipid-soluble antioxidant agent. However, its poor 
bioavailability, rapid metabolism by the liver and intestinal tract, and short biological 
half-life greatly hinders its therapeutic abilities. The water soluble antioxidant, n-2-
mercaptoproprionyl glycine (N-MPG), also has been found to scavenge ROS and 
decrease lipid peroxidation. Like curcumin, its therapeutic efficacy is limited due to its 
poor half-life. In order to improve bioavailability and stability of these two antioxidants, 
lipid vesicle formulations have been designed and characterized for transdermal delivery 
of the antioxidants. Transdermal delivery is a pain-free method of drug delivery that 
allows the antioxidants to permeate through the skin layers for systemic delivery.  
        Three lipid vesicle formulations, traditional liposomes, ultradeformable liposomes, 
and ethosomes, have been fabricated and characterized in order to determine which 
vesicle type has the highest skin permeation through the stratum corneum. Each of the 
three lipid vesicle formulations were composed of 10 mg/ml Soy-PC, 0.48 mg/ml 
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curcumin, and 1 mg/ml N-MPG. The ultradeformable vesicles incorporate an edge 
activator, 1.5 mg/ml cholic acid, into its structure to increase deformability of the 
vesicles. The ethosomes are vesicles composed in a 40% ethanol solution to increase the 
fluidity of the vesicles and skin membrane. The vesicles were characterized for size, 
stability, morphology, and entrapment efficiency. A modified Franz-Diffusion Chamber 
was used to test the skin permeability of each vesicle type. 
        Each particle type was fabricated to have a diameter less than 200 nm. The unloaded 
particle types were tested for stability using a PeroxiDetect Assay, which detected 
amount of lipid hydroperoxides. The ethosomes had the least amount while the 
ultradeformable liposomes had the most. However, when analyzing size of the vesicles 
over various time points, the ultradeformable liposomes were the most stable. Every 
vesicle type had a semi-spherical morphology, with the ultradeformable liposomes 
having the smoothest morphology. The ethosomes had the highest entrapment efficiency 
of curcumin (statistically similar to the traditional liposomes) and N-MPG.  
         The modified Franz-Diffusion chamber was used to characterize skin deposition of 
the vesicles. At hour 2, the ethosomes had the highest fluorescence and consequently, 
skin deposition. At hour 24, the traditional liposomes, which were statistically similar to 
the ultradeformable liposomes, had the highest skin deposition. In the image analysis, the 
ethosomes had the highest sum intensity in the stratum corneum. In the epidermis, the 
traditional liposomes, which were statistically similar to the ethosomes, had the highest 
sum intensity. The traditional liposomes had the highest sum intensity in the dermis layer. 
Subsequently, the ethosomes are recommended for short-term applications of curcumin 
and N-MPG while the traditional liposomes are recommended for long-term applications.  
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        Various cellular processes produce reactive oxygen species (ROS), an oxygen 
containing molecule with an unpaired electron in its outer orbit [1]. The most commonly 
produced cellular ROS molecules are hydroxyl (OH•) and superoxide (O2
- •) [1]. These 
species can be endogenously formed through cellular respiration, respiratory burst, and 
enzymatic reactions.  Exogenous production of ROS can occur via exposure to radiation, 
pollutants, cigarette smoke, food, and drugs [2]. Ionizing radiation creates ROS by 
radiolysis of water or other oxygen containing molecules [2]. Pollutants and cigarette 
smoke contain many highly reactive chemicals, leading to the generation of free radicals 
and ROS. Various food molecules, such as Fe2+, trans fatty acids, phenols, and alcohols, 
can either destabilize chemical reactions to produce ROS or create free radicals upon 
chemical breakdown [2]. The introduction of drugs into the system, for treatments like 
glucocorticoid therapy or volatile anesthetics for surgery, can stimulate oxidative stress, 
forming ROS [2]. 
FIGURE 1 –Sources of ROS. [2] 
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ROS plays a role in many vital physiological processes, including phagocytosis, 
apoptosis, cell signaling, and wound healing [2]. However, an excess of ROS can lead to 
the degeneration of important biomolecules, such as nucleic acids, proteins, lipids, and 
carbohydrates. This excess of ROS can subsequently lead to inactivation of target 
molecules, cause DNA damage, and stimulate apoptosis in cells [2]. Chronic 
overproduction of ROS has been found to lead to the formation of many debilitating 
diseases, such as cancer, diabetes, atherosclerosis, rheumatoid arthritis, chronic 
inflammation, Parkinson’s disease, Alzheimer’s disease, multiple sclerosis, and 
amyotrophic lateral sclerosis [1]. 
        
 The body naturally eliminates ROS by utilizing ROS scavenging compounds, 
called antioxidants. The antioxidant defense system is the body’s way of using enzymatic 
or non-enzymatic methods for eliminating and preventing ROS production. A type of 
natural enzymatic antioxidants are superoxide dismutases. One function of these enzymes 
is to scavenge uncharged H2O2 as it crosses mitochondrial membranes [2]. Thioredoxin is 
an important non-enzymatic antioxidant that regulates redox-sensitive proteins by 
FIGURE 2 –Oxidative stress and human diseases. [1] 
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inhibiting ROS interactions [2].  Overall, antioxidants have the ability to oxidize or 
reduce ROS, bind to ROS precursors, inhibit the formation of ROS, and bind to metal 
ions that subsequently catalyze ROS formation [1][2]. Despite the presence of 
endogenously formed antioxidants in the body, supplemental dietary antioxidants, such as 
vitamin C, vitamin E, vitamin A, and glutathione, are essential for ROS regulation [2]. A 
balance of natural and supplemental antioxidants are needed to effectively remove ROS 
from the physiological system. If ROS production is unmitigated due to insufficient 




Curcumin, also called diferuloyl methane, is a pigment found in turmeric that 
exhibits anti-inflammatory and antioxidant properties [3]. Clinical trials involving high 
doses of curcumin has shown that it is safe, nontoxic, inexpensive, and therapeutically 
effective for a variety of human diseases [3]. Such diseases include cancer, 




cardiovascular disease, arthritis, atherosclerosis, diabetes, renal conditions, Crohn’s 
disease, and many other inflammatory diseases.  
In terms of the antioxidant capabilities of curcumin, there are three potential 
reaction sites where curcumin can react with and eliminate ROS: a diketone (FIGURE 3 
Pathway III) and two phenolic groups (FIGURE 3, Pathways I and II) [5]. As seen in 
FIGURE 3 I and II, ROS reacting with the phenolic groups yields a radical that can be 
transferred around the phenolic group, leading to radical stabilization and elimination. 
When ROS reacts with the carbon in between the diketone groups, like in FIGURE 3 III, 
a radical is formed on the center CH2 group which can be further stabilized by 
transferring electrons throughout the ketone groups. Curcumin’s ability to transfer 
electrons is due to its symmetric structure, beta-diketone, and pi electrons [4][5]. These 
properties of curcumin make it an extremely effective antioxidant, because it is able to 
stabilize free radicals and prevent them from causing damage to biomolecules and 
cellular components. However, despite curcumin’s excellent antioxidant capabilities, its 
therapeutic efficacy is limited due to its own various properties: poor intestinal 
absorption, rapid metabolism, short biological half-life, and low oral bioavailability [3].    
 Curcumin has extremely poor oral bioavailability due to its poor intestinal 
absorption, rapid metabolism, and rapid systemic elimination [3]. Various characteristics 
of curcumin, such as its low water solubility and photosensitivity are thought to hinder its 
ability to be absorbed by the intestines [6]. Intestinal pH was found by Berginc et al to 
also have an effect on curcumin intestinal permeability. In rat jejunum and Transwell 
grown Caco-2 cells, curcumin had a slight increase in permeability under acidic 
conditions, though curcumin permeation was still considered very low [7]. Other factors 
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that limit the intestinal absorption of curcumin are the presence of various intestinal 
enzymes and transporters, such as P-glycoprotein and nonspecific oxydoreductases, that 
metabolize curcumin before reaching systemic circulation [7][6]. Curcumin also has an 
extremely short biological half-life, approximately 0.31±0.07 hours in rats [6]. These 
characteristics of curcumin in physiological conditions lead to the overall poor 
bioavailability of curcumin, rendering this potentially powerful antioxidant essentially 
therapeutically ineffective.  
 
2. n-2-mercaptoproprionyl glycine (N-MPG) 
N-MPG is an aminothiol compound with the ability to scavenge ROS and 
decrease radiation-induced lipid peroxidation [8]. It has been proposed for treatments of 
various conditions, including cystinuria and protection against ischemia-reperfusion 
injury in hypertrophied hearts [8][9]. N-MPG is an effective antioxidant due to its free 
thiol group. The free thiol group is able to be oxidized to create a disulfide bridge with 
another N-MPG molecule, forming disulfide dimers [8]. Despite N-MPG’s antioxidant 
capabilities, N-MPG has limited therapeutic efficacy due to its poor half-life. In 
physiological conditions, N-MPG only has a relative half-life of 1-2 hours [10]. 
FIGURE 4 –Chemical structure of N-MPG [11] 
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3. Current Delivery Methods 
 Various alterations have been made to improve the bioavailability and stability of 
curcumin and N-MPG, separately. Nanoparticle formulations, such as liposomes, nano- 
or micro- emulsions, polymeric nanoparticles, solid lipid nanoparticles, polymer 
conjugates, nanocrystals, polymeric micelles, nanogels, and self-assemblies have been 
intensely studied for improving the therapeutic efficacy of these antioxidants, separately,  
by increasing bioavailability [6] [12] [13]. Most of these modifications have slightly 
improved the oral, injection, and transdermal methods for delivering these antioxidants. 
The goal of this paper is to investigate a method for delivering these antioxidants, 
combined, using transdermal delivery. 
 
C. Transdermal Drug Delivery 
        Transdermal drug delivery is the systemic administration of therapeutic agents by 
penetrating them through the skin. This method of drug delivery is beneficial for 
therapeutic agents, such as curcumin, that are easily degraded by the gastro-intestinal 
tract and/or undergo the first-pass effect of the liver [14]. When orally administered, 
curcumin is usually degraded and unabsorbed by the small intestine, rendering oral 
delivery of curcumin ineffective. Transdermal delivery of curcumin will allow curcumin 
to reach systemic circulation without having to enter the hostile environment of the 
gastro-intestinal tract. Therefore, transdermal delivery of curcumin has the potential to be 
more therapeutically effective compared to oral drug delivery of curcumin. Another 
common method for administering curcumin and N-MPG is through needle injections, 
which are painful and require frequent needle sticks due to fast drug-clearance [14]. 
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Needle injections also have the potential to result in wound site infection, which could 
subsequently lead to sepsis. It also generates dangerous medical waste and can increase 
risk of disease transmission if needles are improperly disposed of [15]. Due to the 
painfulness of the injection method of drug delivery, it also typically has low patient 
compliance. Transdermal delivery does not require frequent injections, allowing for a 
controlled and infection-free delivery of curcumin and N-MPG. Overall, transdermal 
delivery of curcumin and N-MPG has the potential to increase the systemic 
administration of these therapeutic agents in a controlled, non-invasive fashion.   
 The main hindrance for transdermal delivery is penetration of the agent(s) through 
the skin to reach dermal capillaries. Human skin is composed of three main layers: 
epidermis, dermis, and subcutaneous [15]. The stratum corneum is the outermost layer of 
the epidermis and is the main barrier to successful transdermal delivery [15]. The stratum 
corneum is commonly compared to a brick wall, with the bricks being the keratin-rich 
corneocytes and the mortar being the intercellular lipid lamella [15]. The intercellular 
lipid lamella is in a highly organized crystalline structure and is an essential component 
for the barrier properties of the stratum corneum [15]. The other layers of the epidermis 
(stratum lucidium, stratum granulosum, stratum spinosum, stratum basale) also provide 
hindrance for further permeation. Ultimately, the target layer of the skin for transdermal 
drug delivery is the dermis. This layer of the skin contains small capillary vessels; 
therefore, if the drug reaches this layer, the drug can potentially enter the capillaries and 
reach systemic circulation [15].  However in the dermis, capillary hydrostatic pressure, 
lymphatic uptake, and endothelial permeability can provide physical barriers for systemic 
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absorption of the drug. As a first step for transdermal delivery of curcumin and N-MPG, 




D. Lipid Vesicles 
        1. Traditional Liposomes 
One method to penetrate curcumin and N-MPG through the stratum corneum, 
utilizes lipid vesicles, or liposomes.  Liposomes are essentially phospholipids that have 
aggregated in a lipid bilayer(s) to enclose an aqueous medium. Therefore, liposomes have 
the ability to contain lipophilic drugs in their lipid bilayer, such as curcumin, and 
hydrophilic drugs in the encapsulated aqueous medium, such as N-MPG (see FIGURE 6) 
[15]. Because the cell membrane of human cells is composed of a phospholipid bilayer, 
liposomes can be formed that are non-toxic, biodegradable, and a natural permeation 
enhancer [15]. The lipid composition also helps to increase the bioavailability by 
protecting the drug from degradation. Liposomes also have the ability to increase the 
FIGURE 5 –H&E stain of skin, illustrating its layers [14]. 
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stability of the encapsulated drug, which is essential for delivering curcumin and N-MPG 
because of their short half-lives [6][10]. Liposomes also have the potential to provide a 
sustained/controlled release of the drug [15]. After skin permeation to the dermal layer, 
the liposome must pass through capillary endothelial cells to reach systemic circulation.  
During systemic circulation, the liposome will have to circumnavigate phagocytic cells to 
ultimately undergo endocytosis with target cells.  
 
Over the years, modifications have been made to liposomes to increase the 
efficacy of their transdermal delivery. One modification was to add a non-ionic 
amphiphile surfactant to the composition of the vesicles, forming a new type of vesicle 
called niosomes [15]. These vesicles improved penetration, but not into the deeper skin 
tissues. However, with the development of ultradeformable liposomes and ethosomes, by 
Cevc et al and Touitou et al respectively, vesicle penetration through the stratum corneum 
and into the deeper layers of the skin improved drastically [15]. Ultradeformable 
liposomes are liposomes that also contain an edge activator in their lipid bilayer, while 
ethosomes are liposomes that are made in an ethanol/water solution.   




A common method for liposomal fabrication is called the mechanical-dispersion 
method. This method involves dissolving the lipids in a solvent, typically chloroform. 
The lipids are then dried down by evaporating off the solvent. This leaves a film of lipids 
on the container, which is then rehydrated in a buffer solution at 370C for an hour. Probe 
sonication can then be used to break apart the lipids, causing them to aggregate into a 
smaller lipid vesicle. Verma et al, 2002 found that vesicle sizes of 120 nm compared to 
191 nm, 377 nm, and 810 nm had more vesicle permeation through the stratum corneum 
and into the deeper skin layers [17]. Therefore, the main criterion established for particle 
fabrication was to develop particles less than 200 nm, in order to allow for particle 
migration through the skin during transdermal delivery [17].  
2. Ultradeformable Liposomes 
Ultradeformable liposomes are hydrophilic lipid vesicles composed of 
phospholipids and a single chain surfactant called an edge activator. The phospholipid 
typically used in the formation of ultradeformable liposomes are various 
phosphatidylcholines, either soya or egg phosphatidylcholine [15] [18]. Potential edge 
activators include cholic acid; span 60, 65, or 80; and tween 20, 60, or 80 [15][18]. The 
addition of the edge activator to the liposome composition increases the deformability of 








The main mechanism behind increased penetration of ultradeformable liposomes 
is the osmotic gradient of the skin. [15]. Dry skin at the surface of the skin is 
approximately 20% water, while the underlying epidermis is approximately 100% water 
[15][18]. This gradient drives the ultradeformable liposomes movement through the 
brick-walls of the stratum corneum. 
  
FIGURE 7 – Conventional versus Ultradeformable vesicle moving through the stratum 
corneum [18]. 
FIGURE 8 – Osmotic gradient of skin, and subsequent movement of ultradeformable 
liposome [15]. 






100% Water- Low Osmolarity 
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The main method for producing ultradeformable liposomes is the mechanical-
dispersion method described under Traditional Liposomes. The only difference is that 
during the hydration phase of vesicle formation, the lipids are hydrated for 15 minutes at 
430C and then placed in 2-80C for an hour [15]. The vesicles reach their maximum 
hydrodynamic radius at the colder temperature and are later reduced in size with 
processes such as probe sonication, freeze-thaw, and reverse evaporation [15].  
3. Ethosomes 
Ethosomes are lipid vesicles composed of phospholipids, a high concentration of 
ethanol, and water. The typical phospholipids used are either soya phosphatidylcholine 
(Soy-PC) or egg phosphatidylcholine. The ethanol concentration ranges from 20-45% in 
water. Other potential additives include a polyglycol and cholesterol to increase skin 
permeation and increase vesicle stability [15][19]. Typically, the ethosomes made with a 
higher ethanol concentration yielded smaller vesicle diameters and had increased skin 
permeation [15]. 
 
Due to the high concentration of ethanol, ethosomes typically have a very high 
encapsulation efficiency of hydrophilic and lipophilic molecules [15]. It also increases 
the fluidity of the vesicles, as well as the fluidity of the skin layers. The ethanol works to 
FIGURE 9 –Ethosome particle [19]. 
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solubilize the lipid lamella, creating defects in the lipid lamella the fluidic vesicles are 






 Two commonly used methods for fabricating ethosomes include the mechanical-
dispersion method and the cold method. The mechanical dispersion method is similar to 
the process described in the Traditional Liposomes section, except ethanol is incorporated 
into the buffer (20-45%) [19]. The cold method involved dissolving the lipids in ethanol, 
heating this lipid-ethanol solution and heating water to 300C, and then mixing the two 
solutions together with stirring [19]. The lipid vesicles can then be reduced in size 
through probe sonication. 
4. Previous Study 
Previously, fusogenic liposomes were developed by this group using the lipid to 
N-MPG to curcumin ratio 10:1:0.48 (mg/ml) for the purpose of injection delivery. 
Curcumin was trapped inside the lipid bilayer while N-MPG was encapsulated inside the 
aqueous medium of the lipid vesicle. Despite the potential of these fusogenic liposomes, 
the required intravenous injection of this therapy was deemed undesirable. Therefore, an 
alternative method for delivery of curcumin and N-MPG was sought after. 
FIGURE 10 –Schematic of Ethosome movement through skin [20] 
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E. Hypothesis and Specific Aims 
Lipid vesicles containing the antioxidants curcumin and N-MPG can be modified 
to permeate these therapeutic agents passed the stratum corneum of the skin. To address 
this hypothesis, these aims were specified: 
1. Fabrication of traditional liposomes, ultradeformable liposomes, and 
ethosomes containing the antioxidants curcumin and N-MPG that are less 
than 200 nm in diameter. 
2. Characterization of each vesicle for stability, morphology, and entrapment 
efficiency in order to compare vesicle types. 
3. Investigation of the transdermal delivery potential of each type of vesicle 







A. Vesicle Fabrication 
         Using the fusogenic liposomal compositions previously developed by our 
group, the composition of the traditional liposomes was 10 mg/ml Soy-PC, 1 mg/ml N-
MPG, and 0.48 mg/ml curcumin, in a PBS solution. The Soy-PC, specifically 
Phospholipon 90G (Lipoid, Ludwigshafen, Germany), contains 95% soy-
phosphatidylcholine, 2% lyso-phosphatidylcholine, 2% fatty acids, and other lipid soluble 
substances (See FIGURE 11) [21]. The traditional liposomes were fabricated using the 
mechanical-dispersion method. In this method, 250 mg of Soy-PC (95%) was dissolved 
in 1 ml of chloroform and 200 µl of this solution was added to a test tube. Next, 50 mg of 
curcumin (Sabinsa) was dissolved in 2.5 ml of acetone and 120 µl of this solution was 
added to the test tube. The solvents were then evaporated off using a steady stream of 
nitrogen gas, leaving a lipid residue. The lipid residue, or thin film, was then placed 
under vacuum (Thermo, Air Cadet) for 24 hours in order to completely remove any 
remaining solvents. 
  
The lipid residue was then rehydrated by adding 5 ml of a 1 mg/ml N-MPG in 
PBS solution with a pH of 7.4. Two 5 mm glass beads (Sigma) were added to the test 
tube and it was covered with parafilm. The tube was then vortexed for 15 seconds and 
placed in a 37oC water bath for one hour, being vortexed every 15 minutes for 15 
FIGURE 11 –Chemical structure of Soy-PC [21] 
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seconds. The contents of the tube are then removed and placed in a 15 ml centrifuge tube 
for probe sonication (Branson, Sonifer 450). Probe sonication was performed with a 
booster horn and micro-tip probe using a duty cycle of 60% and an output control of 7, 
for five minutes. During sonication, the samples were placed in an ice water bath (16oC-
18oC) with the probe placed in the middle of the centrifuge tube and far down to where 
the centrifuge tube begins to become conical. The solution was then centrifuged with a 
Beckman TJ-6 at the max speed of 10,000 rpm to remove titanium particles form the 
sonicator tip. The supernatant was then removed for particle size analysis using a Protein 
Solutions DynaPro DLS (Wyatt Instruments, Santa Barbara, CA). Samples were stored at 
4oC and protected from light. 
 The ultradeformable liposomes composition was determined to be 10 mg/ml Soy-
PC, 1 mg/ml N-MPG, 0.48 mg/ml curcumin, and 1.5 mg/ml cholic acid (Sigma), in a 
PBS solution [22]. Patel et al similarly developed curcumin loaded transfersomes, 
suggesting a lipid to span 80 ratio of 85:15 (in mmol) for optimal skin permeability of 
curcumin [22]. Span 80, tween 20, and tween 80 were initially attempted for 
ultradeformable liposome fabrication using that lipid to edge activator ratio. Cholic Acid 
was ultimately chosen because compared to the previously mentioned edge activators, it 
created a thin film of lipids, curcumin, and edge activator during fabrication. 
 For the fabrication of the ultradeformable liposomes, the mechanical-dispersion 
methods previously described to make the traditional liposomes was utilized with slight 
modifications. During the drying down phase, 167µL of a 45 mg/ml cholic acid (45 mg 
cholic acid dissolved in 1 mL EtOH) was added to the test tube with the Soy-PC and 
curcumin. The solvents were evaporated and the resulting lipid residue was placed under 
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vacuum, like previously described. During the hydration phase, instead of placing the test 
tube in a 370C water bath for one hour, it was placed in a 430C water bath for 15 minutes 
and then a 2-80C refrigerator for 1 hour. The tube was vortexed for 15 seconds every 15 
minutes. The sonication, centrifugation, sonication, DLS and storage parameters 
remained the same as those described for the traditional liposomes fabrication.  
 For the ethosomes, the initial fabrication technique utilized was the mechanical-
dispersion method described to make the traditional liposomes. The only difference was 
the lipid residue was hydrated in an ethanol solution. To determine what ethanol 
concentration would yield an appropriate vesicle diameter less than 200 nm, 1 mg/ml 
Soy-PC ethosomes in 15%, 30%, 45%, and 70% ethanol solutions were fabricated. A 
40% ethanol solution containing 16.24 mg/ml of Hank’s Balanced Salt Solution (HBSS) 
(Sigma, St. Louis, MO) and 1.33 mg/ml of Trizma base (Sigma) was chosen for future 
ethosome studies. The Soy-PC concentration was increased to 10 mg/ml so the 
ethosomes could be directly compared to the other liposome configurations. The probe 
sonicator duty cycle, or the length of each sonication pulse, was varied between 90%, 
75%, and 60% duty cycle to determine which setting would yield a smaller vesicle 
diameter. The 60% duty cycle was found to yield the smaller vesicle diameter. Next, the 
cold method for ethosome fabrication was tested and found to yield smaller particle sizes 
compared to those made using the mechanical-dispersion methods. Finally, particles were 
sterile filtered (0.2 µm) after fabrication, yielding particles with a diameter less than 200 
nm.  
Thus for characterization and transdermal studies, the fabrication method used 
was the cold method with sterile filtering. For the cold method, 50 mg of Soy-PC 
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(Lipoid) and 2.4 mg of curcumin were dissolved in 2 ml of ethanol in a closed container, 
with stirring. This container was then heated up to 30oC for 15 minutes in a water bath. 
Another solution containing 16.24 mg/ml of HBSS (Sigma) and 1.33 mg/ml of Trizma 
base (Sigma) was also heated up to 30oC for 15 minutes in a water bath. Three ml of the 
HBSS and Trizma base solution and 5 mg of N-MPG were added to the Soy PC, 
curcumin, and ethanol solution. This combination was then stirred for 5 minutes and 
placed in a 15 ml centrifuge tube. The pH of the solution was adjusted to 7.4. The sample 
was sonicated (Branson, Sonifer 450) and centrifuged (Beckman TJ-6) using the same 
settings as those used for the traditional and ultradeformable liposomes. The supernatant 
was removed carefully and then sterile filtered through a 0.2 µm syringe sterile filter into 
a 15 ml centrifuge tube. The size of the particles were then analyzed using DLS. The 
samples were then stored at 4oC and protected from light. 
Dynamic Light Scattering (DLS) analysis was used to ensure the particle sizes 
were less than 200 nm (n=6 per vesicle type. The software package utilized with the DLS 
was Dynamics V6. A model for globular proteins was used to model the particle type, 
and based on the autocorrelation of the intensity during measurement which can be used 
to determine the radius of the particles [23]. The solvent setting used to analyze the 
traditional and ultradeformable liposomes was PBS, while the solvent setting used for the 
ethosomes was 20% Ethanol. Fifty readings were taken for each sample immediately 
after the sample was made. The fifty diameter and polydispersity readings were averaged. 
The means and standard deviations of these averages were recorded. Polydispersity index 
is measure indicating how heterogeneous the sample is. An ANOVA post hoc Tukey test 
(α=0.05) was ran to determine which particle types were statistically similar in size and 
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polydispersity. Minitab 17 was the software used for all statistical analysis performed in 
this paper. 
 
B. Liposome Stability 
1. Lipid Peroxidation     
The stability of each particle type, without curcumin and N-MPG, was analyzed 
using a PeroxiDetect Kit (Sigma). This kit was used to measure the amount of lipid 
hydroperoxides, which form from the oxidation of unsaturated fatty acids. First, a 90% 
methanol stock solution was created by combining 108 mL methanol and 12 mL water. 
The Organic Peroxide Color Reagent was made by adding 120 mL of the 90% methanol 
to the kit bottle. To make the Working Color Reagent, a ratio of 100 volumes of Organic 
Peroxide Color Reagent stock to one volume of Ferrous Ammonium Sulfate Reagent was 
added together. Next, 100 µL of the particle sample being tested was added to a 1.5 mL 
cuvette. Then 1 mL of Working Color Reagent was added to the cuvette. The samples 
were incubated at room temperature for 30 minutes, protected from light. The absorbance 
of the samples was measured with a spectrophotometer (Thermo) at 560nm. A standard 
curve plotting lipid hydroperoxides from 0 to 16 nano-moles versus their respective 
absorbance was created using tert-butyl hydroperoxide as a positive control without 
lipids. This yielded the equation y=0.0408x + 0.0011 with y equaling absorbance and x 
equaling nano-moles of lipid hydroperoxides. The r2=0.9976. It was predetermined that 
the maximum amount of lipid hydroperoxides was 10 nmoles. The PeroxiDetect Kit was 
performed on each particle type at days 0, 3, 7, and 113 post-fabrication. Three samples 
from each particle type was assayed three times. The total mean absorbance and standard 
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deviation was used to calculate the mean nano-moles of lipid hydroperoxides and 
standard deviation of each particle type. A one-way ANOVA with α=0.05 was used to 
determine which particle type minimizes the amount of nano-moles of lipid 
hydroperoxides over time. Equal variance was tested prior to running the ANOVA. If 
equal variance could be assumed then a Tukey comparison was ran. Otherwise, a Games-
Howell comparison was ran.  
2. Size Analysis 
The stability of each particle type, with curcumin and N-MPG, (n=6) was also 
analyzed by taking size measurements using DLS analysis at various time points post-
fabrication [24]. Time measurements include day 0, 3, 7, 14, and 30, post fabrication as 
these days would likely show liposome aggregation or liposome destruction via lipid 
peroxidation. The particle type was determined unstable once the mean particle size was 
statistically different from day 0 or once the mean particle size had changed a 
predetermined percentage. A one-way ANOVA post hoc Tukey (α=0.05) was used to 
determine if particle size at each time point differed significantly from day 0. The other 
metric for determining particle stability involved taking the 50 measurements from each 
particle batch at day 0 and finding the mean and standard deviation for that sample. The 
standard deviation percentage of the mean was then found by dividing the standard 
deviation by the mean and multiplying by 100. This was then averaged for ethosomes, 
traditional liposomes (n=6 for both), or ultradeformable liposomes (n=4) to yield the 
criteria for allowable percent change in size. For ethosomes, ultradeformable liposomes, 
and traditional liposomes, the allowable percent change is 34.5%, 22.5 %, and 32.8%, 
respectively. The percent change in mean particle size from day 0 was found by taking 
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the mean particle size at day X subtracted by the mean particle size at day 0, divided by 
mean particle size at day 0, and multiplied by 100.  
 
C. Liposome Characterization Using SEM 
        Scanning Electron Microscopy (SEM) was used to examine the shape and size of the 
liposome formulations. In order to visualize the liposomes, 15 µL of the sample was 
pipetted onto carbon tape on a copper stub and left to dry for over 12 hours. The samples 
were sputter coated with gold/palladium in a 0.1 torr vacuum with a voltage of 1.8 kV for 
two minutes. A Zeiss Supra 35VP scanning electron microscope using a secondary 
electron detector with an EHT value ranging from 1.50 kV to 3.00 kV was used to 
visualize each particle type.  
 
D. Entrapment Efficiency 
The entrapment efficiency of curcumin for each lipid vesicle type was determined 
using the ultracentrifugation method [25]. A Beckman L8-70M Ultracentrifuge with a 
50.4 TI rotor was used to spin down three 1 mL aliquots of each sample (n=3) for 30 
minutes at 40,000 rpm. Once finished, the supernatant of each sample was removed. The 
supernatant was diluted in PBS, using a 50 to 950 sample to PBS volumetric ratio. A 
spectrophotometer (Thermo) read the absorbance at a fixed wavelength of 425 nm. Two 
concentration curves were created to determine the amount of curcumin in the 
supernatants of the samples. The first concentration curve initially dissolved curcumin in 
100% methanol to create a 1 mg/ml solution, because curcumin is extremely insoluble in 
water. In order to mimic the solutions used to fabricate the traditional and 
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ultradeformable liposomes, subsequent dilutions were performed with a 1 mg/ml N-MPG 
in PBS solution. This first concentration curve was graphed from 25 µM to 1000 µM of 
curcumin, yielding the equation y=0.003x – 0.0726, r2=0.9771, with y equal to 
absorbance and x equal to curcumin concentration. This was then used to determine the 
amount of curcumin in the supernatants of the traditional liposome and ultradeformable 
lipsome samples. The second concentration curve was created by dissolving and diluting 
curcumin in 40% EtOH, in order to mimic the solution of the ethosomes. This second 
concentration curve was graphed from 25 µM to 400 µM of curcumin, yielding the 
equation y=0.0038x + 0.1802, r2=0.9958 with y equal to absorbance and x equal to 
curcumin concentration. This equation was then used to determine the amount of 
curcumin in the supernatant of the ethosome samples. Entrapment efficiency was then 
calculated as a percent using the equation [25]: 
% 𝐸𝑛𝑡𝑟𝑎𝑝𝑚𝑒𝑛𝑡 =  
𝐶𝐶𝑀𝑓𝑎𝑏 − 𝐶𝐶𝑀𝑠𝑢𝑝𝑒𝑟𝑛𝑎𝑡𝑎𝑛𝑡
𝐶𝐶𝑀𝑓𝑎𝑏
 × 100 
The percent entrapment calculations from the three aliquot readings from each individual 
particle batch were averaged together. A one-way ANOVA post hoc Tukey test (α=0.05) 
was then used to determine if particle type significantly affected entrapment efficiency 
and if so, which type had the highest. 
A typical method for quantifying the amount of N-MPG in a solution is by using 
Ellman’s Reagent to bind to N-MPG’s free thiol group. Once bound, TNB is released and 
ionizes to TNB2- in water. TNB2- is a yellow color and can be read at a wavelength of 412 
nm on a spectrophotometer. However, this reading is masked by curcumin because it 
reads at a wavelength of approximately 425 nm. Therefore, the entrapment efficiency of 
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N-MPG by each vesicle type was theoretically calculated using the equation in FIGURE 
12. 
 
 The entrapment efficiency is a percentage of the inner volume of the vesicle (Vin) 
over the total volume of the sample (V) [26]. Inner volume is a function of the radius of 
the particle (rin), the bilayer thickness (d), the lipid concentration (c), the amount of lipid 
molecules per vesicle (NA), and the exposed area of a single lipid molecule (a). The 
calculation is repeated with probability weights (Pi) over a log normal distribution of 
vesicle sizes [26]. For each particle type, the bilayer thickness (d) was assumed to be 4.9 
nm [26], the mean molecular area of a single lipid molecule (a) was assumed to be 40 Å 
[26], the lipid concentration (c) of the sample was10 mg/ml or 12.9 mM, and sample 
volume (V) was 5 mL. The particle size and size distribution of each particle type was 
FIGURE 12 –Schematic of Theoretical Entrapment Efficiency [26] 
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chosen to be the diameter and standard deviation reported in the “Vesicle Fabrication” 
section of the results.        
E. Skin Permeation 
        In order to determine if the lipid vesicles were able to penetrate into the dermis layer 
of skin, testing was performed using pig skin and a modified Franz diffusion chamber 
[26]. The pig skin came from the abdominal region of one year old Yucatan or Yorkshire 
pigs immediately after they were sacrificed. Upon excision, the skin was washed with 7.4 
pH PBS and stored at 40C for a maximum of two days. Fat and muscle layers were 
removed from the skin layers using a scalpel.   
 
A Franz Diffusion Chamber is an apparatus that allows one to determine the 
pharmacokinetics of a transdermal treatments. The typical Franz Diffusion Chamber can 
be viewed in FIGURE 13. Compartment 1 is the donor compartment that houses the 
treatment being tested [27]. Below this compartment is where the skin is placed. 
Compartment 2 houses a warm circulating solution where the sample will travel once it 
has migrated through the skin [27]. The traditional Franz Diffusion Chamber was 
recreated using a 12 cell well plate and its respective cell culture insert (FIGURE 14).  




The excised skin was cut into circular pieces using a metal cylinder approximately 
10 mm in diameter. The circular skin pieces were then placed into the 12 cell well cell 
culture insert with the dermis layer facing downward. The skin was fastened and sealed 
to the cell culture insert by placing 20 µL of surgical glue (Vetbond Tissue Adhesive) 
around the edges of the skin. Once the glue dried, 1.25 mL of the vesicle treatment was 
placed on top of the skin. The cell inserts were placed on white paper for 5 minutes and 
analyzed for leakage before being used. A stir bar and 700 µL of PBS-Ascorbic Acid 
(100 µL of 1M ascorbic acid/2.9 mL PBS) were placed into each cell well. Then, the skin 
cell culture insert with treatment was added to the cell well. Once a 12 cell well plate was 
filled with skin cell culture inserts, the top was secured and the cell plate was wrapped in 
parafilm and aluminum foil. It was then placed in a 370C room on top of a stir plate.  
 
 






The skin permeation of the three liposome formulations was examined over a 24 
hour time period. A Thermoscientific NanoDrop 2000c Spectrophotometer was used to 
take absorbance measurements of the solution in the lower chamber at hours 2, 8, 18, and 
24. Control treatments include PBS and free curcumin in PBS, while liposome treatments 
include drug-loaded ethosomes, ultradeformable liposomes, and traditional liposomes. 
Each treatment had a skin-containing cell insert with an n=2.  Three absorbance readings 
were taken from each cell well by placing 2 µL of the sample onto the NanoDrop reader. 
However, the use of the NanoDrop Spectrophotometer was deemed not sensitive enough 
to detect the curcumin that permeated the skin.  
The skin permeation study was replicated, taking fluorescence measurements 
using a fluorometer, (Turner) instead of taking absorbance measurements using the 
NanoDrop. A fluorometer was thought to detect lower concentrations of curcumin 
FIGURE 15 –Image of cell well insert with skin and treatment, in the 12 cell well plate.  
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compared to the NanoDrop. A Turner Biosystems Modulus with the Blue LED (465 nm 
to 485 nm wavelength) was used to measure Fluorescent Specific Units of the solution 
contained in the cell well. 125 µL of the sample was placed in glass microtube and read. 
The time points for this study were hours 2, 7, 17, 24, and 41. However, this measure was 
also determined not sensitive enough. 
Since utilizing the NanoDrop and fluorometer were determined to be ineffective 
in measuring lipid vesicle permeation, another measure determining amount of lipid 
vesicles deposited in the skin was performed. In this testing, the modified Franz 
Diffusion Chamber was set up like previously described. Treatments performed were a 
PBS control (n=3) and each lipid vesicle formulation (ethosomes: n=4; ultradeformable 
and traditional liposomes: n=3). After 24 hours in the modified Franz Diffusion 
Chamber, the Yorkshire pig skin sections were removed from cell culture inserts with a 
scalpel and placed in 2 mL centrifuge tube with 1 mL of 200 proof EtOH to extract 
curcumin deposited in the skin. The centrifuge tubes were then placed in an ultrasonic 
bath (Fisher Scientific FS60) for 1 hr [29]. Three fluorescence readings were then taken 
from each sample using the Turner Biosystems fluorometer. Skin deposition was also 
determined at hour 2(PBS: n=3; ethosomes: n=4; ultradeformable and traditional 
liposomes: n=3). A one-way ANOVA post hoc Tukey (α=0.05) was used to determine if 
treatment affected skin deposition and to compare treatments. 
The Yorkshire pig skin from the skin permeation study involving the NanoDrop 
reader was post-processed. The skin was removed from the cell culture insert with a 
scalpel and then placed in 4% formaldehyde for 48 hours. Next, the skin was placed into 
a 30% sucrose solution for a minimum of 48 hours or until the tissue sank to the bottom 
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of its container. Then, the tissue was embedded in a tissue mold (Peel-A-Way ®) by 
freezing the tissue in optimal cutting temperature (Tissue-Tek ®) compound using dry 
ice. Once frozen, the tissue block was covered in aluminum foil and stored at -800C. A 
cryotome (Thermo Electron Corporation Shandon FSE), with the cryobar -500C, the 
chamber -200C, and the specimen -200C, cut the blocks of tissue into 30 µm sections. 
Once cut, the sections were placed onto microscope slides. Slides from each treatment 
type was used for imaging the curcumin fluorescence in the skin and for histological 
staining of the skin.  
A hematoxylin and eosin stain (H&E) was performed on the cut skin samples in 
order to differentiate the skin layers. First, the microscope slides were heated on a hot 
plate at 650C for 20 minutes. Then the tissue was hydrated in DI water for 2 minutes, two 
times. The slides were then placed in 0.1% Hematoxylin (Sigma) for 10 minutes. Then 
the sections were washed with tap water three times, each for 1 minute. The microscope 
slides were then dipped in 0.5% Eosin Y in 95% EtOH (Sigma) for 15 seconds. The eosin 
was then washed off twice with DI water. The tissue was dehydrated by placing the slides 
in increasing ethanol concentrations: 50%, 70%, 95%, and100%. The microscope slides 
were placed in each ethanol solution for two minutes, two times. Then the slides were 
placed in xylene for 1 minute before a coverslip was attached with Permount [30]. The 
H&E stained slides were then imaged with a digital inverted microscope (Evos xL Core, 
Waltham, MA) using a magnification of 40x, a brightness of 84, and a cool color balance. 
Three pictures were taken for each treatment. The images were then loaded into the NIS 
Elements program in order to measure two lengths: the top of skin to the bottom of 
stratum corneum and the bottom of stratum corneum to the bottom of epidermis. Three 
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length measurements were taken for each skin layer in each image by measuring from the 
two outer edges and the middle of the skin (see FIGURE 16). These length measurements 
were used for fluorescent image analysis.  
 
A confocal microscope (Nikon Eclipse Ti) was used to capture fluorescent images 
of the cut skin tissue using NIS Elements software. Since curcumin naturally fluoresces 
green when exposed to blue light, any curcumin or curcumin containing particle can be 
visualized using fluorescent microscopy. Appropriate sections were found using the 
bright field setting. The light source was switched to green fluorescent protein (GFP) 
with an excitation wavelength of 488 nm. The control PBS treated skin had brightness 
and color automatically adjusted to minimize auto-fluorescence of the tissue. These 
settings were then used to image the remainder of the skin treatments. All pictures were 
taken on 60x magnification. Three images, bright field and GFP, were taken per 
treatment. 
FIGURE 16 –Example image of length measurements taken of H&E stained tissue. 
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To analyze the fluorescent images, the skin layer lengths determined from the 
H&E stain were used. Three boxes, each a 35 X 35 µpixels, were drawn per skin layer 
per image. They were randomly placed in each skin layer by using the lengths found from 
the H&E stain. Another box was drawn outside of the skin to determine background 
noise. The boxes were then analyzed to find the sum intensity of each box. The sum 
intensity of the background box was subtracted from the other box measurements taken 
from that image to remove the noise. This was done for each treatment: PBS, free 
curcumin in PBS (control treatment), ethosomes, ultradeformable liposomes, and 
traditional liposomes. The sum intensity from the PBS condition was averaged for each 
skin layer. These averages were then subtracted from the sum intensities found for the 
other treatments in order to remove natural skin fluorescence from their measurements. 
Therefore, any excess fluorescence found in the skin layers is from the curcumin in the 
treatments. A one-way ANOVA post hoc Tukey (α=0.05) was performed for each skin 
layer-- stratum corneum, epidermis, and dermis-- to determine if treatment affects Sum  
Intensity and if so, which treatment corresponds to the highest fluorescence in the skin 
layer.  
 





A. Vesicle Fabrication 
        In order to fabricate the traditional liposomes, the common mechanical-dispersion 
method was chosen for its ease of use. Soy-PC was utilized as the bilayer forming lipid in 
all particle formulations because it is commonly used in the development of 
ultradeformable liposomes and ethosomes [15][18]. This lipid and the concentration of 10 
mg/ml Soy-PC was kept consistent across all particle types, so the additives that caused 
varying particle characteristics could be pinpointed.  
The mechanical-dispersion method was utilized during the fabrication of the 
ultradeformable liposomes. Initially, the ultradeformable liposomes were made using 
span 80 as the edge activator. However, during the drying down phase of fabrication, the 
solvent of the span 80 would not evaporate, yielding a viscous solution containing trace 
amounts of chloroform and acetone. Tween 20 and tween 80 were also attempted to be 
used as an edge activator yielding similar results. Therefore, the lipid residue could not be 
created with these surfactants, preventing further fabrication. Cholic acid was then tried 
with successful results, rendering it the edge activator of choice.  
The original method used for ethosome fabrication was the mechanical dispersion 
method. The concentration of ethanol to be used for the hydrating solution was tested by 
making the particles in various ethanol concentrations. A high ethanol concentration is 
desired, because it typically leads to increased skin permeation [19]. For these trials, a 





Contrary to literature findings, the higher ethanol concentrations yielded larger 
vesicle diameters [19]. Therefore, in order to decrease the vesicle diameter and still 
maintain a high ethanol concentration, a 40% ethanol, 16.24 mg/ml HBSS (Sigma), and 
1.33 mg/ml Trizma base (Sigma) solution was chosen to make future ethosomes. The 
HBSS and Trizma base were added to the ethanol solution as buffers.  
Since the size of the ethosomes remained greater than 200 nm, the sonication duty 
cycle was varied to determine the optimal duty cycle setting.  The duty cycle determines 
the length of each sonication pulse. Sonication introduces a high amount of sound energy 
into the solution, causing the lipids to rearrange into smaller vesicles. However, this high 
energy can also cause the generation of lipid hydroperoxides, leading to instability and 
ultimate degradation of the vesicles. The desired duty cycle setting is low, while still 
creating small vesicle sizes. The sonication duty cycle chosen was 60%, because it was 
lower and yielded particle sizes comparable to the 75% and 90% duty cycles.  
 





















Ethanol Concentration vs Particle Size: 1 




Next, the cold method for ethosome fabrication was attempted to lower particle 
size. After running the particles through a 0.2 µm syringe sterile filter, the particles 
decreased to a diameter below 200 nm. Therefore, the cold method, 40% ethanol, a duty 
cycle of 60%, and a sterile filter were used for ethosome fabrication for all subsequent 
studies. These parameters were only examined with the ethosomes because the vesicle 
types were inherently less than 200 nm, unlike the ethosomes.  
FIGURE 19 –Effect of probe sonicator duty cycle on ethosome size (n=1) 
FIGURE 20 –Effect of fabrication technique on ethosome size n=1. Graphed 











































Ideal particle sizes are less than 200 nm for vesicle skin permeation [17]. In order 
to ensure particle sizes were below this value, DLS analysis was performed on each 
particle type (n=6). Fifty measurements were performed for each reading. Size 
measurements and polydispersity are reported in TABLE 1. Liposome type was found to 
statistically affect particle size (p=0.015) and polydispersity (p=0.030). The ethosomes 
and ultradeformable liposomes were found to be statistically different in particle size 
(p=0.012) while the ethosomes and traditional liposomes were statistically different in 
polydispersity (p=0.028).  
TABLE I 
MEAN PARTICLE DIAMETER AND POLYDISPERSITY 
Particle Type Diameter mean (nm) ± 
standard deviation (nm) 
Polydispersity mean (%) ± 
standard deviation (%) 
Traditional 
Liposomes 




81.63 ± 18.22* 55.93 ± 24.06 




In conclusion, all vesicle types were made with 10 mg/ml Soy PC, 0.48 mg/ml 
curcumin, and 1 mg/ml N-MPG. The traditional liposomes and ultradeformable 
liposomes were made using the mechanical-dispersion method. The ultradeformable 
liposomes also contained 1.5 mg/ml cholic acid. These two particle types were easily less 
than 200 nm in size. In order to make the ethosomes less than 200 nm in size, they had to 
*denotes statistically different.  
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be fabricated using the cold method, 40% ethanol, a sonication duty cycle of 60%, and 
sterile filtered.  
B. Liposome Stability 
1. Lipid Peroxidation 
The lipid peroxidation of the non-drug loaded particles was analyzed using a 
PeroxiDetect Kit (Sigma) (FIGURE 21). This kit detects the amount of lipid 
hydroperoxides in a sample. Once lipid hydroperoxides form, they propagate throughout 
the sample causing the lipid vesicles to degrade. The antioxidants in the drug-loaded 
particles can quench lipid hydroperoxides; however, this limits their therapeutic 
effectiveness. Therefore, understanding when the lipid hydroperoxides start to form is 
important for determining vesicle stability and efficacy. The PeroxiDetect Assay was 
performed on days 0, 3, 7, and 113 on each vesicle type. Three samples from each 
particle type was assayed three times.  
A one-way ANOVA post hoc Tukey test (α=0.05) was performed to determine 
which particle type minimizes lipid hydroperoxide formation at each day. Equal variance 
could be assumed for days 0, 3, and 7. At days 0, 3, and 7, particle type was found to 
statistically affect amount of lipid hydroperoxides, with p values equal to 0.000, 0.000, 
and 0.001 respectively. At days 0 and 3, all three liposomes were statistically different, 
with the ethosomes containing the least hydroperoxides (Day 0: p<0.003, Day 3: 
p<0.008) and the ultradeformable liposomes containing the most (Day 0: p<0.003, Day 3: 
p<0.001). At day 7, the ethosomes and traditional liposomes were statistically similar 
(p=0.282) and had the minimal amount of lipid hydroperoxides (p<0.005). At day 113, 
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the one-way ANOVA showed that all three particle types were statistically similar 
(p=0.518). 
To determine which days are significantly different in lipid hydroperoxide amount 
after initial post-fabrication, a one-way ANOVA with α=0.05 was performed on each 
particle type. This showed that days statistically affected lipid hydroperoxide amount for 
ethosomes, ultradeformable liposomes, and traditional liposomes (p= 0.000 for each 
vesicle type). Equal variance could not be assumed for the ethosomes and traditional 
liposomes. For the ethosomes, each day was statistically different with day 0 having the 
minimal amount of lipid hydroperoxides (p<0.025). In the traditional liposomes, day 3 
had the minimal amount of lipid hydroperoxides (p<0.028), followed by statistically 
similar days 0 and 7 (p>0.999).  Equal variance was assumed for the ultradeformable 
liposomes (p= 0.546). Day 3 had minimal lipid hydroperoxides (p<0.020) followed by 












2. Size Analysis 
In order to determine the stability of the drug-loaded vesicles, the change in 
particle diameter was analyzed over various time points using a one-way ANOVA 
(α=0.05) and using a predetermined allowable change in size percentage from day 0. The 
ANOVA found that particle size was not statistically significant between the differing 
time points for the ethosomes (p=0.062) and ultradeformable liposomes (p=0.402). 
However, post-fabrication day was found to be statistically significant for the traditional 
liposomes (p=0.000); days 0 and 3 are statistically different from days 7, 14, and 30 
(p<0.009 and p<0.001).  
 
FIGURE 21 – Amount of Lipid Hydroperoxides for liposome at day 0 (A). Amount of 
Lipid Hydroperoxides at days post-fabrication for Ethosomes (B), Ultradeformable 




























































































































The percent changes in mean diameter size from day 0 in each particle type can 
be seen in TABLE II. The ethosomes exceed their allowable percent change from day 0 
of 34.5% in between days 3 and 7. The ultradeformable and traditional liposomes do not 
exceed their predetermined percent change from day 0 of 22.5% and 32.8%, respectively.  
 
TABLE II 
PERCENT CHANGE IN PARTICLE MEAN DIAMETER FROM DAY 0 
 Percent change in Mean Diameter (%) 




0-3 32.4 2.63 5.65 
0-7 74.5 6.80 20.9 
0-14 75.7 6.21 22.5 
0-30  7.84 20.7 
FIGURE 22 –Mean diameter of Traditional Liposomes at various days post-fabrication. * 

























In conclusion, the ethosomes initially have the least amount of lipid 
hydroperoxides compared to the ultradeformable and traditional liposomes. However, 




















Mean Ultradeformable Liposome Sizes





















FIGURE 23 –Mean diameter of ethosomes at various days post-fabrication. † denotes 
percent change from day 0 exceeds predetermined limit. 




and 7 time points. The ultradeformable liposomes have the highest initial amount of lipid 
hydroperoxides; however, the mean diameters do not significantly change from day 0 to 
day 30. The traditional liposomes have a statistically significant change in diameter from 
day 3 to day 7. Therefore, the ethosomes and traditional liposomes are stable until day 3 
while the ultradeformable liposomes are stable until day 30.  
 
C. Liposome Characterization Using SEM 
An SEM image was used to ensure appropriate particle formation and 
morphology. FIGURE 24A shows ethosome particle formation, EHT=2.00kV. 
Ethosomes appear semi-spherical and vary in size. Figure 24B shows the ultradeformable 
liposomes at an EHT=3.00kV. The ultradeformable liposomes exhibit a smooth and 
spherical morphology with varying vesicle sizes. The traditional liposomes are shown in 
Figure 24C at an EHT=2.00kV. They appear to have a semi-spherical formation with 














FIGURE 25 – STEM images of (A) ethosomes, (B) ultradeformable liposomes, and (C) 









D. Entrapment Efficiency 
 
The ultracentrifugation method was used to determine curcumin entrapment 
efficiency of each particle type. The three absorbance readings from one sample were 
averaged together. These averages were used to run a one-way ANOVA post hoc Tukey 
(α=0.05), which determined that vesicle type affects entrapment efficiency of curcumin 
(p=0.008). Ethosomes had the highest entrapment efficiency of curcumin, 92.4%  ± 
4.69%,  and was statistically different from the ultradeformable liposomes,  82.1%  ± 
5.27% (p=0.001). The traditional liposomes had an entrapment efficiency of 88.1% ± 
3.17%. Traditional Liposomes were statistically similar to the ethosomes (p=0.189) and 
the ultradeformable liposomes (p=0.061). These entrapment efficiencies yield a true 
curcumin concentration in the ethosomes of 0.44 mg/ml, in the ultradeformable 
liposomes of 0.39 mg/ml, and in the traditional liposomes of 0.42 mg/ml. 
The entrapment efficiency of N-MPG was calculated theoretically, by taking the 
percentage of inner vesicle volume over total volume of the sample. The ethosomes had 
the highest entrapment efficiency of N-MPG of 3.08%. The ultradeformable liposomes 
had the lowest N-MPG entrapment efficiency of 1.92%. The traditional liposomes had an 
entrapment efficiency of 2.94%. The ethosomes having the highest entrapment efficiency 
of curcumin and N-MPG was expected due to their larger hydrodynamic radius. These 
entrapment efficiencies yield a theoretical N-MPG concentration in the ethosomes of 
0.031 mg/ml, in the ultradeformable liposomes of 0.019 mg/ml, and in the traditional 




ENTRAPMENT EFFICIENCY OF CURCUMIN AND N-MPG OF VESICLES 
Particle Type Actual Entrapment Efficiency of 




Efficiency of N-MPG 
(%) 
Ethosomes 92.4 ± 4.69  3.08 
Ultradeformable 
Liposomes 
82.1 ± 5.27* 1.92 
Traditional Liposomes 88.1 ± 3.17  2.94 
 
 
E. Skin Permeation 
In order to quantify skin permeation of the vesicles, a modified Franz Diffusion 
chamber was created using a 12 well plate and Transwell cell culture inserts to simulate 
an apical and basal layer of skin. Pig skin was fixed to the cell culture insert and 
treatments were placed on top of the skin. Absorbance measurements were taken from the 
media below the insert inside the cell well using a NanoDrop spectrophotometer 
(Thermo) at various time points. Most of the treatments were too similar to the control 
PBS readings to detect differences, while the ultradeformable liposomes had extreme and 
questionable variability. This could be due to machine insensitivity. Also, the surgical 
glue used to secure the skin samples to the cell culture inserts could have clogged the 
membrane pores, preventing permeation into the bottom chamber. Curcumin could have 
also degraded, hindering absorption measurements.  
 




Therefore, fluorescence was measured using a fluorometer (Turner Biosystems). 
FIGURE 27 shows these results. Once again, this form of measurement was determined 
unreliable because of the little difference from the PBS control treatment. Once again, 



















































FIGURE 27 –Skin Permeation measurements taken with a Fluorometer. 
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Quantifying the amount of vesicles permeating through the skin was proving 
unsuccessful. Therefore, the amount of vesicles depositing in the skin was quantified. An 
ultrasonic bath (Fisher Scientific) was used to release the vesicles from the skin. 
Fluorescence readings were then taken. This was performed applying treatments for 2 
and 24 hours. A one-way ANOVA post hoc Tukey (α=0.05) showed that particle type 
significantly affects skin deposition at hours 2 and 24 (p=0.000 and p=0.000, 
respectively). At hour 2, all particle types had statistically higher fluorescence then the 
control PBS treatment (p<0.000) as expected. The particle treatment that exhibited the 
highest skin deposition was the ethosomes (p=0.000), followed by the ultradeformable 
liposomes. The particle type that had the lowest fluorescence was the traditional 
liposomes.  
 
At hour 24, the control treatment, PBS, expectedly exhibited the least amount of 
fluorescence and was statistically different from all other treatments (p<0.010).  The 
































particle treatment that had the highest fluorescence was the traditional liposomes, which 
was also statistically similar to the ultradeformable liposomes (p=0.972). Out of the 
particle types, the ethosomes had the lowest skin deposition at hour 24.  
 
 
From the skin deposition results, one can conclude that the ethosomes penetrate 
the skin faster, while the traditional liposomes and ultradeformable liposomes permeate 
more slowly. Over time, the permeation of the ultradeformable liposomes and traditional 
liposomes increases, exceeding the amount of ethosomes permeating.  
In order to visualize the particles permeated into the skin, image analysis was 
performed. An H&E stain was performed to visualize the skin layers and to determine the 
approximate depth of each layer. Also, any differences in skin structure after the 
treatments were examined.  
 
 
































FIGURE 30 –H&E stained sections of treated pig skin, with magnified stratum corneum 
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The average length and standard deviation of the stratum corneum is 25.72 µm ± 9.02 
µm. The average length and standard deviation of the epidermis is 61.25 µm ± 21.42 µm. The 
only visual differences among the treated skin versus the PBS control skin can be seen in the 
stratum corneum. In the ethosome and ultradeformable liposome treatments, the stratum corneum 
















































FIGURE 31 –Bright field and GFP images of treated skin. 
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The fluorescent images were taken using a confocal microscope and analyzed 
using NIS Elements software. Sum intensity measurements were taken for each skin layer 
for each treatment. A one-way ANOVA (α=0.05) found that particle type significantly 
affected image sum intensity for the stratum corneum (p=0.001), the epidermis 
(p=0.000), and the dermis (p=0.000). The curcumin control group was the group with the 
minimal sum intensity for each skin layer. Equal variance could not be assumed for 
comparing particle type in the stratum corneum layer (approximately 0-25 µm depth); 
therefore, a Games-Howell post hoc was used. This analysis showed that the ethosome 
treated skin had the highest sum intensity and were statistically different from the control 
curcumin group (p=0.002). The ultradeformable liposomes were the next highest 
treatment but were not statistically different from the curcumin control group (p=0.203) 
or the traditional liposomes (0.372). The traditional liposomes were next and weren’t 
statistically different from the control group (p=0.726) or ultradeformable liposomes.  
Equal variance could be assumed for the epidermis and dermis layer; therefore, a 
post hoc Tukey test was used to compare the particle types. In the epidermis layer 
(approximately 25-86 µm depth), the traditional liposomes maximized the sum intensity 
and were statistically different from the curcumin control (p=0.000). The next 
maximizing treatment was the ethosomes which were statistically similar to the 
traditional liposomes (p=0.149) and the curcumin control (p=0.072). The ultradeformable 
liposomes were the least maximizing of the particle types and were statistically similar to 
the control curcumin group (p=1.000). For the dermis layer (approximately 86 µm and 
greater in depth), a post hoc Tukey showed that the sum intensity for the traditional 
liposomes maximized the sum intensity and was statistically different from the curcumin 
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control group (p=0.000). The ultradeformable liposomes were not statistically different 


































FIGURE 32 –Image fluorescence analysis. Skin permeation depth was obtained from 
H&E depth measurements. * denotes statistically different. 
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IV. CONCLUSIONS, DISCUSSION, & FUTURE WORK 
 In conclusion, three lipid vesicle formulations, traditional liposomes, 
ultradeformable liposomes, and ethosomes, were designed for combined transdermal 
delivery of two antioxidants, curcumin and N-MPG. All vesicles were less than 200 nm 
in diameter and were characterized for stability, morphology, entrapment efficiency, and 
transdermal delivery.  
 The ultradeformable and traditional liposomes were fabricated using the 
mechanical-dispersion method. The ethosomes were fabricated using the cold method 
and running the particles through a 0.2 µm sterile filter. These fabrication techniques 
yielded vesicle sizes under the predetermined diameter limit of 200 nm.   
The stability of the unloaded vesicles was determined using a PeroxiDetect Kit to 
analyze the amount of lipid hydroperoxides. The particle type that inherently had the 
minimal nano-moles of lipid hydroperoxides was the ethosomes, followed by the 
traditional liposomes. However, from days 0 to 7, all of the lipid vesicles are under the 
predetermined acceptable limit of 10 nmoles of lipid hydroperoxides. By day 113, all of 
the lipid vesicles exceeded this limit. A potential issue with the results obtained from the 
kit is that the phosphate in the lipid vesicle buffers could have interacted with the 
solutions in the kit to cause higher absorbance readings. Therefore, the results are 
representative of trends in lipid hydroperoxide formation. Also, the amount of lipid 
hydroperoxides is expected to be much less with the presence of curcumin and N-MPG, 
and hence more stable, because the antioxidants can quench their formation.  
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The stability of the drug-loaded vesicles was also determined by measuring the 
size of the particle types at various time points. The ultradeformable liposomes did not 
statistically change in size or exceed the predetermined allowable amount of percent 
change in size. At day 7, the traditional liposomes were statistically different in size from 
day 0; however, they never exceeded their allowable percent change in size. The 
ethosomes were not statistically different in size at measured time points; however, they 
did exceed their allowable percent change in between days 3 and 7.  
The morphology of each particle type was examined using SEM imaging. The 
ultradeformable liposomes had the smoothest and most spherically shaped vesicles. The 
ethosomes and the traditional liposomes were semi-spherically shaped, but were not as 
smooth. The particle type that had the highest actual entrapment efficiency of curcumin 
was the ethosomes; however, they were statistically similar to the traditional liposomes. 
The ultradeformable liposomes had the lowest entrapment efficiency of curcumin and N-
MPG. The ethosomes, once again had the highest theoretical entrapment efficiency of N-
MPG. However, these theoretical entrapment efficiencies of N-MPG are still rather low.  
Based on these results, the particles with the best stability and morphology are the 
ultradeformable liposomes. The ethosomes had the best entrapment efficiency and were 
statistically similar to the traditional liposomes. For the skin deposition studies, all 
particle types had statistically higher fluorescence (α=0.05) than the PBS control. At hour 
2, the ethosomes had the highest fluorescence and were statistically different from all 
other treatment types. This indicates that the ethosomes have the quickest penetration into 
the skin. At hour 24, the traditional liposomes had the highest fluorescence and were only 
statistically similar to the ultradeformable liposomes. This indicates that over time, the 
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traditional liposomes and ultradeformable liposomes increase in permeation. The 
decrease in ethosome permeation could be due to particle breakdown because of their 
relative instability. The pig skin is also potentially degrading, introducing pores, bacteria, 
and other extraneous factors that could affect the results. 
The image analysis showed that the ethosomes had the highest sum intensity in 
the stratum corneum and were statistically different from the free curcumin control. In the 
epidermis, the traditional liposomes had the highest sum intensity, were statistically 
different from the free curcumin control, and also statistically similar to the ethosomes. 
The traditional liposomes had the highest sum intensity in the dermis and were the only 
treatment statistically different from the free curcumin control. The ethosomes have the 
potential to be statistically different from the free curcumin control (p=0.057). Since this 
image analysis was only performed with an n=1, increasing the number of replicates will 
provide a better understanding of the potential of each treatment. However, these results 
strongly indicate that the ethosomes and traditional liposomes permeate into and through 
the stratum corneum. 
For future work, the stability of the ethosomes and liposomes may need to be 
increased by adding additional lipid soluble antioxidants. While curcumin is a lipid 
soluble ROS scavenger, the location of the curcumin in the membrane bilayer is similar 
to cholesterol. In this model, the phenolic hydroxyl groups of curcumin are close to the 
water penetration space between adjacent phospholipids. The addition of alpha-
tocopherol (Vitamin E), a known membrane antioxidant, could decrease ROS production 
from the unsaturated fatty acids. Another approach is to use a base composition of 
phospholipids that contains less unsaturated phospholipids. During fabrication, using a 
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homogenizer as opposed to a probe sonicator to decrease particle size could increase 
stability as well. Probe sonication introduces ultrasound pulses into the solution, creating 
excessive particle motion and high heat, leading to the formation of the degrading lipid 
hydroperoxides. A homogenizer forces the particles through small pores, hence limiting 
their size without the high temperatures.  
Another future PeroxiDetect Assay performed on the particles with the lipids 
extracted out of their buffer solutions may need to be completed to yield a more true 
representation of vesicle stability.  Also, more image analysis needs to be performed to 
increase the sample size. The current sample size is just an n=1; therefore, the current 
result is only a trend and qualitative assessment.  
Ultimately, the particle treatments are going to be incorporated into a transdermal 
patch, and future skin permeation studies will be performed. For applications requiring 
short-term drug delivery of curcumin and N-MPG, such has a person needing immediate 
relief from radiation poisoning, the ethosomes seem to be the best particle type. The 
ethosomes had the quickest skin deposition and with further studies, may prove to reach 
the deeper skin layers. Unless the stability of these particles are not improved upon, their 
usefulness for more long-term applications, such as protection from extended radiation 
exposure, appears to be limited. The particles that seem to be best for these types of 
applications are the traditional liposomes. They are the particles that had the highest skin 
deposition at hour 24 and the highest sum Intensity in the dermis skin layer.   
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